Emil Adolf von Behring and serum therapy for diphtheria.
作者信息
Raju Tonse N K
机构信息
National Institute of Child Health and Human Development, National Institutes of Health, Maryland, Bethesda 20892, USA.
出版信息
Acta Paediatr. 2006 Mar;95(3):258-9. doi: 10.1080/08035250600580586.
PMID:16497632
Abstract
摘要
相似文献
1
Emil Adolf von Behring and serum therapy for diphtheria.埃米尔·阿道夫·冯·贝林与白喉血清疗法
Acta Paediatr. 2006 Mar;95(3):258-9. doi: 10.1080/08035250600580586.
2
["Blood is a very special juice"--introduction of serum therapy for diphtheria in Norway].["血液是一种非常特殊的汁液”——挪威白喉血清疗法的介绍]
Tidsskr Nor Laegeforen. 2014 Sep 30;134(18):1780-1. doi: 10.4045/tidsskr.14.0406.
3
Danish contributions to the evaluation of serum therapy for diphtheria in the 1890s.19世纪90年代丹麦人对血清疗法治疗白喉的评估所做的贡献。
J R Soc Med. 2011 May;104(5):219-22. doi: 10.1258/jrsm.2010.10k073.
4
Horses and the diphtheria antitoxin.马与白喉抗毒素
Acad Med. 2000 Apr;75(4):396. doi: 10.1097/00001888-200004000-00022.
5
[Throat disease in the periphery of Europe: the introduction of diphteria antitoxin in Romsdal county].[欧洲边缘地区的咽喉疾病：罗姆达尔郡对白喉抗毒素的引进]
Tidsskr Nor Laegeforen. 2014 Apr 8;134(7):732-5. doi: 10.4045/tidsskr.13.0783.
6
The drug that launched a thousand sleds.开启千般雪橇之旅的药物。
Mol Interv. 2008 Aug;8(4):152-8. doi: 10.1124/mi.8.4.2.
7
The Nobel Prize for Medicine or Physiology, 1901, awarded to Emil Adolf von Behring.1901年诺贝尔生理学或医学奖授予埃米尔·阿道夫·冯·贝林。
Scand J Immunol. 1989 Jul;30(1):3-12.
8
Public health and the production and use of diphtheria antitoxin in Philadelphia.费城的公共卫生以及白喉抗毒素的生产与使用
Bull Hist Med. 1987 Summer;61(2):216-36.
9
The Nobel chronicles. 1901: Emil Adolf von Behring (1854-1917).
Lancet. 1998 Jul 4;352(9121):75. doi: 10.1016/s0140-6736(05)79565-9.
引用本文的文献
1
Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy.用于预防和治疗呼吸道合胞病毒、严重急性呼吸综合征冠状病毒 2 型、人类免疫缺陷病毒、狂犬病和细菌感染的单克隆抗体：来自世界传染病和免疫疾病协会以及意大利抗感染治疗学会的最新更新。
Front Immunol. 2023 May 15;14:1162342. doi: 10.3389/fimmu.2023.1162342. eCollection 2023.
2
Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.杂交瘤技术是一种分离单克隆抗体的通用方法，其在不同物种中的适用性、局限性、进展和未来展望。
Int Immunopharmacol. 2020 Aug;85:106639. doi: 10.1016/j.intimp.2020.106639. Epub 2020 May 27.
3
Adverse Effects of Immunoglobulin Therapy.免疫球蛋白治疗的不良反应。
Front Immunol. 2018 Jun 8;9:1299. doi: 10.3389/fimmu.2018.01299. eCollection 2018.
4
Contribution of physiologists to the identification of the humoral component of immunity in the 19th century.19世纪生理学家对免疫体液成分识别的贡献。
MAbs. 2017 Jul;9(5):774-780. doi: 10.1080/19420862.2017.1325051. Epub 2017 May 30.
5
The 1925 Diphtheria Antitoxin Run to Nome - Alaska: A Public Health Illustration of Human-Animal Collaboration.1925年白喉抗毒素运往阿拉斯加诺姆市——人兽协作的公共卫生实例
J Med Humanit. 2019 Sep;40(3):287-296. doi: 10.1007/s10912-016-9428-y.
Zotero 插件